Kenneth Binmoeller | |
---|---|
![]() Photo of Dr. Kenneth Binmoeller | |
Education | |
Occupation | Surgeon |
Known for |
|
Medical career | |
Field | Gastroenterology |
Institutions | California Pacific Medical Center |
Awards |
|
Website | Kenneth Binmoeller on LinkedIn |
Kenneth Frank Binmoeller is a medical doctor and author of multiple scientific contributions [1] and over 300 publications, [2] [3] as well as the inventor of the lumen-apposing metal stent (LAMS) [4] [5] and AXIOS System. [6] [7] These are medical devices used to relieve blockages while creating a direct connection between two bodily structures. [8] He practices in the field of Gastroenterology with a specialty of Advanced Endoscopic Intervention. [9] [10] Binmoeller has been published for his innovations in medical devices and training in the field of Endoscopy. [11]
Binmoeller studied Medicine at the Albert Ludwigs University and graduated in 1983 before he attended medical school at the University of Freiburg in Germany and then at the University of Bern in Switzerland. He completed his Residency in Internal Medicine at the Baylor College of Medicine in Houston, Texas, and followed his residency by working as an attending physician in Honokaa, Hawaii while at Hamakua Medical Center, Honokaa Hospital. Binmoeller then completed a Fellowship in Gastroenterology at the Oregon Health & Science University in Portland. [12] [13] Having completed his fellowship, Binmoeller joined the University Hospital (Hôpital Cimiez) at Cimiez in Nice, France. [14]
In 1991, Binmoeller was recruited by and mentored under Dr. Nib Soehendra, known for numerous contributions as a pioneer in the field of therapeutic endoscopy, [15] while at the University Hospital Eppendorf in Hamburg. [16] Binmoeller served as Deputy Director and Senior Consultant in the Department of Endoscopic Surgery. [17]
Binmoeller relocated back to the United States after seven years in Hamburg, taking the position of Director of Endoscopy at the University of California at San Diego (UCSD) while holding a joint appointment as Associate Professor of Medicine and Science. [18] [17] Binmoeller is certified in gastroenterology and internal medicine by the American Board of Internal Medicine. [19]
He has been certified to practice in the states of:
Binmoeller was affiliated with the California Pacific Medical Center (CPMC) in San Francisco, CA, working as the Medical Director of the Interventional Endoscopy Services (IES). [18] His work in the field of endoscopic procedures is amongst the presentations of the New Frontiers Course, held annually. [23]
Binmoeller has been performing procedures in the field of interventional endoscopy since the 1980s. [24] [25] [12] Throughout his career as a medical specialist, he has also held university appointments in both Europe and the United States. These include:
In 2001, Binmoeller founded the Interventional Endoscopy Services (IES) at the CPMC, Van Ness Campus and Mission Bernal Campus. [27] This center was founded by Binmoeller, with him as acting Medical Director. The center's focus was on innovating and enabling new procedures in interventional endoscopy while improving existing techniques and technologies. [12] [28]
He has collaborated with multiple device manufacturers in an effort to improve existing products. He is also the clinical founder of several medical device start-ups:
Binmoeller is owner of over 100 Endoscopic Technology patents. [37] His first patent was filed in 1998 for an endosonographic guided tissue sampling device. [38] Development and global commercialization was assigned to the Olympus Medical Corporation, which brought the NA-11J-KB Powershot [39] needle to market. He is the inventor of the Lumen-Apposing Metal Stent (LAMS). His work on this was published in the Lumen-Apposing Stents, An Issue of Gastrointestinal Endoscopy Clinics, book. [40] [41] [25]
ISP has mentored and trained multiple endoscopists from all across the globe [42] and launched a postgraduate program, The International Scholars Program in Advanced Endoscopy, in 2002 in collaboration with Sutter Health and California Pacific Medical Center. Binmoeller supervised a group of endoscopists and nurses, such as Dr. Janek Shah, Dr. Yasser Bhat, and Dr. Chris Hamerski. Its one-year training program reviews a broad spectrum of interventional endoscopic procedures, as well as various techniques like underwater resection of colonic polyps, endoscopic closure of gastrointestinal defects, and endoscopic therapy of subepithelial lesions, among other procedures. [25] [43] [44] Financial support for scholars is provided by Endovision for ISP. [45]
The Endovision Foundation was Founded by Binmoeller in 2015 in San Francisco, California, [46] and he is the current President and Chief Executive Officer, overseeing management and direction. [47] [48]
Binmoeller invented the AXIOS system for advanced interventional endoscopy. This has two components, the AXIOS Stent and a cautery-enabled access catheter, to provide an Electrocautery Enhanced Delivery System. The system allows an endoscopist to access walled-off necrosis and symptomatic pancreatic pseudocysts by means of a transduodenal or a trans gastric approach to then place the AXIOS stent. [49]
This was the first system of its kind in the United States and is currently the only minimally invasive approach that entirely streamlines the process. [50] [51]
In April 2015, Xlumena was acquired by Boston Scientific [52] when they agreed to pay $62.5 million with an additional $12.5 million for sales-based milestones [53] [54] upon FDA clearance of HOT AXIOS, [55] to go alongside the AXIOS Delivery System, [56] which had already received FDA 510(k) clearance [57] as the world’s first stent designed specifically for Endoscopic Ultrasound (EUS) guided transluminal drainage of symptomatic pancreatic pseudocysts. [58] [59] [60]
{{cite book}}
: CS1 maint: others (link) [72] Gastroenterology is the branch of medicine focused on the digestive system and its disorders. The digestive system consists of the gastrointestinal tract, sometimes referred to as the GI tract, which includes the esophagus, stomach, small intestine and large intestine as well as the accessory organs of digestion which include the pancreas, gallbladder, and liver.
In medicine (gastroenterology), angiodysplasia is a small vascular malformation of the gut. It is a common cause of otherwise unexplained gastrointestinal bleeding and anemia. Lesions are often multiple, and frequently involve the cecum or ascending colon, although they can occur at other places. Treatment may be with colonoscopic interventions, angiography and embolization, medication, or occasionally surgery.
Endoscopic retrograde cholangiopancreatography (ERCP) is a technique that combines the use of endoscopy and fluoroscopy to diagnose and treat certain problems of the biliary or pancreatic ductal systems. It is primarily performed by highly skilled and specialty trained gastroenterologists. Through the endoscope, the physician can see the inside of the stomach and duodenum, and inject a contrast medium into the ducts in the biliary tree and/or pancreas so they can be seen on radiographs.
Enteroscopy is the procedure of using an endoscope for the direct visualization of the small bowel. Etymologically, the word could potentially refer to any bowel endoscopy, but idiomatically it is conventionally restricted to small bowel endoscopy, in distinction from colonoscopy, which is large bowel endoscopy. Various types of enteroscopy exist, as follows:
Endoscopic ultrasound (EUS) or echo-endoscopy is a medical procedure in which endoscopy is combined with ultrasound to obtain images of the internal organs in the chest, abdomen and colon. It can be used to visualize the walls of these organs, or to look at adjacent structures. Combined with Doppler imaging, nearby blood vessels can also be evaluated.
Ascending cholangitis, also known as acute cholangitis or simply cholangitis, is inflammation of the bile duct, usually caused by bacteria ascending from its junction with the duodenum. It tends to occur if the bile duct is already partially obstructed by gallstones.
Stretta is a minimally invasive endoscopic procedure for the treatment of gastroesophageal reflux disease (GERD) that delivers radiofrequency energy in the form of electromagnetic waves through electrodes at the end of a catheter to the lower esophageal sphincter (LES) and the gastric cardia – the region of the stomach just below the LES. The energy heats the tissue, ultimately causing it to swell and stiffen; the way this works was not understood as of 2015, but it was thought that perhaps the heat causes local inflammation, collagen deposition and muscular thickening of the LES and that it may disrupt the nerves there.
Hemosuccus pancreaticus is a rare cause of hemorrhage in the gastrointestinal tract. It is caused by a bleeding source in the pancreas, pancreatic duct, or structures adjacent to the pancreas, such as the splenic artery, that bleed into the pancreatic duct, which is connected with the bowel at the duodenum, the first part of the small intestine. Patients with hemosuccus may develop symptoms of gastrointestinal hemorrhage, such as blood in the stools, maroon stools, or melena, which is a dark, tarry stool caused by digestion of red blood cells. They may also develop abdominal pain. It is associated with pancreatitis, pancreatic cancer and aneurysms of the splenic artery. Hemosuccus may be identified with endoscopy (esophagogastroduodenoscopy), where fresh blood may be seen from the pancreatic duct. Alternatively, angiography may be used to inject the celiac axis to determine the blood vessel that is bleeding. This may also be used to treat hemosuccus, as embolization of the end vessel may terminate the hemorrhage. However, a distal pancreatectomy—surgery to remove of the tail of the pancreas—may be required to stop the hemorrhage.
A self-expandable metallic stent is a metallic tube, or stent that holds open a structure in the gastrointestinal tract to allow the passage of food, chyme, stool, or other secretions related to digestion. Surgeons insert SEMS by endoscopy, inserting a fibre optic camera—either through the mouth or colon—to reach an area of narrowing. As such, it is termed an endoprosthesis. SEMS can also be inserted using fluoroscopy where the surgeon uses an X-ray image to guide insertion, or as an adjunct to endoscopy.
An endoclip is a metallic mechanical device used in endoscopy in order to close two mucosal surfaces without the need for surgery and suturing. Its function is similar to a suture in gross surgical applications, as it is used to join together two disjointed surfaces, but, can be applied through the channel of an endoscope under direct visualization. Endoclips have found use in treating gastrointestinal bleeding, in preventing bleeding after therapeutic procedures such as polypectomy, and in closing gastrointestinal perforations. Many forms of endoclips exist of different shapes and sizes, including two and three prong devices, which can be administered using single use and reloadable systems, and may or may not open and close to facilitate placement.
Therapeutic endoscopy is the medical term for an endoscopic procedure during which treatment is carried out via the endoscope. This contrasts with diagnostic endoscopy, where the aim of the procedure is purely to visualize a part of the gastrointestinal, respiratory or urinary tract in order to aid diagnosis. In practice, a procedure which starts as a diagnostic endoscopy may become a therapeutic endoscopy depending on the findings, such as in cases of upper gastrointestinal bleeding, or the finding of polyps during colonoscopy.
An endoscopy unit refers to a dedicated area where medical procedures are performed with endoscopes, which are cameras used to visualize structures within the body, such as the digestive tract and genitourinary system. Endoscopy units may be located within a hospital, incorporated within other medical care centres, or may be stand-alone in nature.
Herpes esophagitis is a viral infection of the esophagus caused by Herpes simplex virus (HSV).
Cholecystostomy or (cholecystotomy) is a medical procedure used to drain the gallbladder through either a percutaneous or endoscopic approach. The procedure involves creating a stoma in the gallbladder, which can facilitate placement of a tube or stent for drainage, first performed by American surgeon, Dr. John Stough Bobbs, in 1867. It is sometimes used in cases of cholecystitis or other gallbladder disease where the person is ill, and there is a need to delay or defer cholecystectomy. The first endoscopic cholecystostomy was performed by Drs. Todd Baron and Mark Topazian in 2007 using ultrasound guidance to puncture the stomach wall and place a plastic biliary catheter for gallbladder drainage.
Endoscopic stenting is a medical procedure by which a stent, a hollow device designed to prevent constriction or collapse of a tubular organ, is inserted by endoscopy. They are usually inserted when a disease process has led to narrowing or obstruction of the organ in question, such as the esophagus or the colon.
Todd Huntley Baron is an American gastroenterologist who is Professor of Medicine at the University of North Carolina School of Medicine. Additionally, he currently serves as the Director of Advanced Therapeutic Endoscopy within UNC's Division of Gastroenterology and Hepatology. He is known for his publishing in the field of gastroenterology particularly in endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS) and other advanced endoscopic procedures. He has developed interventional endoscopic techniques for the care of patients with gastrointestinal, liver and other medical conditions. He was the first to describe endoscopic drainage of the gallbladder, placement of a colonic stent, and endoscopic pancreatic necrosectomy.
Michel Kahaleh is an American gastroenterologist and an expert in therapeutic endoscopy.
Pancreatic mucinous cystic neoplasm (MCN) is a type of cystic lesion that occurs in the pancreas. Amongst individuals undergoing surgical resection of a pancreatic cyst, about 23 percent were mucinous cystic neoplasms. These lesions are benign, though there is a high rate of progression to cancer. As such, surgery should be pursued when feasible. The rate of malignancy present in MCN is about 10 percent. If resection is performed before invasive malignancy develops, prognosis is excellent. The extent of invasion is the single most important prognostic factor in predicting survival.
Nib Soehendra is a German surgeon known for numerous contributions to the field of endoscopy and therapeutic endoscopy.
Pankaj "Jay" Pasricha is a physician and researcher specializing in gastroenterology and neurogastroenterology. He currently serves as the chair of medicine at the Mayo Clinic in Scottsdale, Arizona. Formerly, he served as the director of the Johns Hopkins Center for Neurogastroenterology and was the founder and co-director of the Amos Food, Body and Mind Center, Vice Chair of Medicine for Innovation and Commercialization in the Johns Hopkins School of Medicine, and Professor of Innovation Management at the Carey Business School.
{{cite book}}
: CS1 maint: others (link):{{cite book}}
: CS1 maint: location (link)